These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 16127006)

  • 1. Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
    Ferraccioli GF; Tomietto P; De Santis M
    Ann N Y Acad Sci; 2005 Jun; 1051():658-65. PubMed ID: 16127006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospects of the use of cyclosporin A in rheumatic diseases].
    Nasonov EL; Shtutman VZ; Nasonova VA
    Klin Med (Mosk); 1994; 72(5):12-9. PubMed ID: 7853807
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
    Fox DA; McCune WJ
    Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug immunosuppression].
    Seipelt H
    Kinderarztl Prax; 1975 Jul; 43(7):308-25. PubMed ID: 51111
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].
    Szegedi G
    Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
    Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
    Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cyclosporin in autoimmune diseases].
    Follath F; Fontana A; Leumann E; Michel BA; Miescher PA; Schreier M; Schroeder M; Wenk M
    Schweiz Med Wochenschr; 1994 Jul; 124(27-28):1232-9. PubMed ID: 8052828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunosuppressive agents].
    Lagrue G; Bariéty J; Druet P
    Acquis Med Recent; 1970; ():43-61. PubMed ID: 5526182
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our experiences with Imuran treatment].
    Golacka K; Tarka Z
    Pol Tyg Lek; 1971 Mar; 26(10):345-6. PubMed ID: 5550676
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppressive therapy in management of non-malignant disease.
    Fennelly JJ; Fitzgerald MX; Fitzgerald O
    J Ir Med Assoc; 1970 Apr; 63(394):141-6. PubMed ID: 5418154
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal antibodies and fusion proteins and their complications: targeting B cells in autoimmune diseases.
    Lee S; Ballow M
    J Allergy Clin Immunol; 2010 Apr; 125(4):814-20. PubMed ID: 20371395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoreactive diseases in pregnancy].
    Donat H
    Zentralbl Gynakol; 1986; 108(16):961-73. PubMed ID: 3535311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive therapy].
    Purice S
    Stud Cercet Med Interna; 1973; 14(3):209-16. PubMed ID: 4574134
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulatory B cells in autoimmune diseases: how do they work?
    Lemoine S; Morva A; Youinou P; Jamin C
    Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term therapy of immunologic diseases with special reference to the use of immunosuppressive agents].
    Scheiffarth F; Warnatz H
    Dtsch Med Wochenschr; 1969 Nov; 94(47):2444-9. PubMed ID: 4310731
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological actions of cyclosporin A in rheumatoid arthritis.
    Yocum D
    Br J Rheumatol; 1993 Mar; 32 Suppl 1():38-41. PubMed ID: 8448635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortistatin as a potential multistep therapeutic agent for inflammatory disorders.
    Gonzalez-Rey E; Delgado M
    Drug News Perspect; 2006 Sep; 19(7):393-9. PubMed ID: 17080202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T cell immunity in autoimmune disease].
    Fujio K
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():56-60. PubMed ID: 15861635
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cyclosporin for the treatment of systemic autoimmune diseases].
    Tanaka Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():240-6. PubMed ID: 15954356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.